Brainstorm cell stock
WebApr 10, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Brainstorm Cell Therapeutics stock is Buy based on the current 1 buy rating for BCLI. The average twelve-month price prediction for Brainstorm Cell Therapeutics is $10.00 with a high price target of $10.00 and a low price target of $10.00. WebTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the …
Brainstorm cell stock
Did you know?
WebMar 28, 2024 · Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) traded at $1.60 at close of the session on Monday, 03/27/23, made an upward move of 3.23% on its previous day’s price. Looking at the stock we see that its previous close was $1.55 and the beta (5Y monthly) reads -0.36 with the day’s price range being $1.56 – $1.92. WebApr 6, 2024 · BCLI Earnings Date and Information. Brainstorm Cell Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 27th, 2024 based off prior year's report dates. Read More.
WebApr 8, 2024 · Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. The official website for the company … WebHistorical daily share price chart and data for Brainstorm Cell Therapeutics since 2024 adjusted for splits. The latest closing stock price for Brainstorm Cell Therapeutics as of …
WebApr 11, 2024 · What is Brainstorm Cell Therapeutics Inc’s stock style? BCLI’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. WebBrainStorm Cell Therapeutics Inc. Restricted Stock Agreement Granted Under 2005 U.S. Stock Option and Incentive Plan EX-10.10 9 v231506_ex10-10.htm EX-10.10 Exhibit 10.10
WebApr 12, 2024 · Brainstorm Cell Therapeutics is trading at a lower price-to-earnings ratio than Codiak BioSciences, indicating that it is currently the more affordable of the two stocks.
WebMar 29, 2024 · Stock Performance. Shares of Brainstorm Cell were trading at $1.84 as of March 28. Over the last 52-week period, shares are down 41.67%. Given that these returns are generally negative, long-term ... mtech batteryWebApr 5, 2024 · Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. - Part 3 how to make payment to anz credit cardWebApr 12, 2024 · Brainstorm Cell Therapeutics Inc (BCLI) stock is trading at $2.63 as of 3:26 PM on Wednesday, Apr 12, a decline of -$0.23, or -8.22% from the previous closing … how to make payment system in websiteWebGet the latest Brainstorm Cell Therapeutics Inc (BCLI) real-time quote, historical performance, charts, and other financial information to help you make more informed … m-tech batteriesWebBCLI Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. BRAINSTORM CELL THERAPEUTICS INC. BRAINSTORM CELL THERAPEUTICS INC. 3.41 ... how to make payment to great easternWebApr 8, 2024 · Brainstorm Cell Therapeutics is not a large company by global standards. It has a market capitalization of US$134m, which means it wouldn't have the attention of many institutional investors ... mtech baton reviewWebMar 21, 2024 · Brainstorm Cell Therapeutics has a beta of -0.44, suggesting that its stock price is 144% less volatile than the S&P 500. Comparatively, Passage Bio has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. how to make payments on fnb app